|
|
|
|
|
|
by refurb
2009 days ago
|
|
|
Exactly. Plus dating tends to get extended post-approval. If Pfizer has a short-list of candidates back in May, they could have had 6 months of stability data at approval. They can keep those studies going and by next May have 12 months of data for the FDA to review and potentially update the transportation and storage requirements. |
|
|